Aclarion Inc
NASDAQ:ACON
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Aclarion Inc
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.
